Table 2. IP-10, MCP-1, MIP-1α, MIP-1β, RANTES, and VEGF in serum samples from diabetic and control participants (pg/mL).
| Diabetics | Controls | s | |
|---|---|---|---|
| Mean +/− SD (Range) | Mean +/− SD (Range) | p-value | |
| IP-10 | 346.20 (287.36) | 328.74 (352.35) | 0.88 |
| 28.06–1586.90 | 56.06–2809.70 | ||
| MCP-1 | 133.10 (89.10) | 141.47 (222.15) | 0.5 |
| 10.00–360.90 | 10.00–1850.34 | ||
| MIP-1 α | ** | ** | - |
| MIP-1β | 184.40 (100.20) | 139.56 (151.38) | 0.003* |
| 43.07–403.61 | 9.21–1187.32 | ||
| RANTES | 51336.23 (19940.31) | 33629.25 (33301.01) | 0.002* |
| 5800.00–99600.0 | 22.30–129100.0 | ||
| VEGF | 304.88 (257.52) | 154.45 (114.78) | <0.001* |
| 10.00–1196.40 | 10.00–563.34 |
Interferon-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, macrophage inflammatory protein (MIP)-1β, RANTES (regulated upon activation, normal T-expressed and secreted) and vascular endothelial growth factor (VEGF) levels in the serum of diabetics and control samples given in picograms per milliliter. The single asterisk (*) indicates significant after Bonferroni correction p<0.006 (α=0.05) and the double asterisk (**) indicates, that the factor was below the detection limit. SD means standard deviation.